Comparison of Gemcitabine and Anthracycline Antibiotics in Prevention of Superficial Bladder Cancer Recurrence

BMC Urology - United Kingdom
doi 10.1186/s12894-019-0530-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nucleotide Excision Repair Gene Polymorphisms and Recurrence After Treatment for Superficial Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Metformin for the Prevention of Bladder Cancer Recurrence: Is It Effective?

Nephro-Urology Monthly
Urology
2016English

Fuzzy Modelling for Predicting the Risk of Recurrence and Progression of Superficial Bladder Tumors

Applied Mathematics
2018English

Microbial Conversion of Anthracycline Antibiotics.

Journal of Antibiotics
Drug DiscoveryPharmacology
1975English

Photodynamic Diagnosis of Superficial Bladder Cancer by Using Fluorescence

Nippon Laser Igakkaishi
2008English

1,25D3 Enhances Antitumor Activity of Gemcitabine and Cisplatin in Human Bladder Cancer Models

Cancer
Cancer ResearchOncology
2010English

A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane

Cancer Research and Treatment
Cancer ResearchOncology
2002English

Radiation Sterilization of Anthracycline Antibiotics in Solid State

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Analysis of Factors Affecting Reccurence and Prognosis of Superficial Bladder Cancer

Japanese Journal of Urology
Urology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy